Stem Cell Therapy for Kidney Disease
Support renal function and tissue repair with regenerative MSC therapy.
Understanding Kidney Disease
Chronic kidney disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood. Affecting over 800 million people globally, CKD can result from diabetes, high blood pressure, glomerulonephritis, or polycystic kidney disease.
As kidney function declines, waste products accumulate in the body, leading to complications including anemia, bone disease, cardiovascular problems, and eventual kidney failure requiring dialysis or transplantation. The condition is classified in five stages based on glomerular filtration rate (GFR).
Conventional treatment focuses on managing underlying causes and slowing progression through blood pressure control, dietary modifications, and medications. Regenerative medicine introduces the possibility of supporting kidney tissue repair and reducing the fibrosis that drives progressive kidney damage.
Common Symptoms
- Fatigue and weakness
- Swelling in legs, ankles, or feet (edema)
- Changes in urination frequency or volume
- Shortness of breath
- Nausea and appetite loss
- Persistent itching
- Elevated blood pressure
How MSC Therapy May Help
MSCs may support kidney health through their anti-fibrotic, anti-inflammatory, and regenerative properties. Kidney fibrosis, the scarring that replaces functional kidney tissue, is a primary driver of CKD progression. MSCs have shown the ability to reduce fibrotic activity by modulating the cells responsible for scar tissue formation.
The anti-inflammatory effects of MSCs are critical for kidney disease, as chronic inflammation accelerates tubular damage and glomerular injury. MSCs may help suppress inflammatory pathways, protect kidney tubular cells from further damage, and promote the survival of functional nephrons.
Additionally, MSCs release vascular endothelial growth factor (VEGF) and other angiogenic factors that support the repair of damaged blood vessels within the kidney. Healthy blood flow is essential for kidney filtration, and improved vascularization may support better overall renal function.
Our Treatment Approach
Renal Function Assessment
Comprehensive kidney evaluation including GFR, creatinine, BUN, proteinuria levels, and imaging to determine the stage and pattern of kidney damage.
IV MSC Infusion
Systemic intravenous delivery of MSCs targeting renal inflammation, fibrosis reduction, and support for remaining nephron function.
Anti-Fibrotic Support
Exosome co-therapy and complementary treatments designed to amplify the anti-fibrotic and regenerative effects of MSC therapy on kidney tissue.
Monitoring & Follow-up
Regular monitoring of kidney function markers, dietary guidance, and coordination with your nephrologist to track improvements and adjust care.
Expected Benefits
- May support preservation of kidney function
- May help reduce renal fibrosis and scarring
- Supports reduction of kidney inflammation
- May improve blood flow to kidney tissue
- Promotes protection of remaining nephrons
- May complement existing kidney disease management
Frequently Asked Questions About Kidney Disease
While extensive kidney damage may not be fully reversible, MSC therapy may help slow progression, reduce fibrosis, and support the function of remaining healthy tissue. Patients in earlier stages of CKD may experience greater preservation of kidney function.
MSC therapy is not a replacement for dialysis in advanced kidney failure. It is best considered as a supportive treatment that may help preserve kidney function in earlier stages of CKD, potentially delaying the need for dialysis. Your nephrologist remains central to your overall care plan.
Patients with Stage 2-4 CKD generally have the most to gain from MSC therapy, as there is still functional kidney tissue that can be supported and protected. The medical team evaluates each case individually to determine suitability and set realistic expectations.
Kidney function markers such as GFR and creatinine are monitored at 3, 6, and 12 months post-treatment. Improvements, when they occur, typically develop gradually as inflammation decreases and tissue repair progresses.
Ready to Explore Your Treatment Options?
Schedule a personalized consultation to discuss how MSC therapy may support your health journey.